MedTrace Logo

Readmissions of Lung Transplant Patients in ICU.

NCT03767049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2018-12-06

No results posted yet for this study

Summary

A multi-centre, prospective and observational study was carried out from August 2012 to June 2016 in five Spanish tertiary-care university hospitals with well-established lung transplant programs: Vall d'Hebron (Barcelona), Marqués de Valdecilla (Santander), 12 de Octubre (Madrid), CHUAC (A Coruña), and Reina Sofía (Córdoba).

The study population comprised all consecutive adult lung transplant recipients who required ICUr (after \>7 days post-transplant discharge from ICU) during august 2012 - June 2016 (4-yr period).

Conditions

  • Lung Transplant; Complications

Interventions

OTHER

Colection of clinical data

Colection of clinical data

Sponsors & Collaborators

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Cristopher Alan Mazo Torre, MD · 0

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-01
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03767049 on ClinicalTrials.gov